NASDAQ:RCKTW Rocket Pharmaceuticals (RCKTW) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free RCKTW Stock Alerts $0.12 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.12▼$0.1250-Day Range$0.07▼$0.3552-Week Range$0.05▼$0.50VolumeN/AAverage Volume23,299 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Rocket Pharmaceuticals alerts: Email Address Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here About Rocket Pharmaceuticals Stock (NASDAQ:RCKTW)Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.Read More RCKTW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCKTW Stock News HeadlinesMay 6, 2024 | sfgate.comRocket Pharmaceuticals: Q1 Earnings SnapshotMay 6, 2024 | detroitnews.comDefending champ Rickie Fowler one of 3 top-40 players to commit to Rocket Mortgage ClassicMay 2, 2024 | msn.comFortnite Rocket Racing: Neon Rush Released; Whats New?May 1, 2024 | msn.comReport: Glass exterior at Rocket Mortgage FieldHouse needs new coating to prevent birds from flying into itMay 1, 2024 | msn.comCleveland Cavaliers host a playoffs watch party at Rocket Mortgage FieldhouseMay 1, 2024 | msn.comRonnie O'Sullivan is hailed for one of the 'greatest bits of sportsmanship ever' during clash with Stuart Bingham... but the Rocket reveals he just 'wanted to prove the referee ...April 28, 2024 | msn.comDavid Reinbacher Gained Valuable Experience With the Laval RocketApril 26, 2024 | msn.comWhat Exactly Is A HIMARS Rocket System?April 26, 2024 | reuters.comSouth Korea's Hanwha to supply more rocket launchers to Poland for $1.64 blnApril 24, 2024 | finance.yahoo.comShould You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?April 21, 2024 | msn.comEliminated from playoffs, Laval Rocket end season with home-ice lossApril 18, 2024 | msn.comRocket Lab gearing up to refly Electron booster for 1st timeApril 15, 2024 | in.investing.comCiti lifts Coupang to Buy after Rocket Wow subscription fee raiseApril 11, 2024 | investing.comRocket Pharmaceuticals executive sells over $308k in company stockApril 11, 2024 | msn.comU.S. Space Force, Rocket Lab set new partnership that includes big Virginia launchApril 11, 2024 | msn.comIn Russia's Far East, a New Heavy-Lift Rocket Blasts off Into Space After Two Aborted LaunchesApril 10, 2024 | msn.comFortnite Rocket Racing: How to Get the Werewolf CarApril 10, 2024 | markets.businessinsider.comOptimistic Buy Rating for Rocket Pharmaceuticals Based on Strong Gene Therapy Pipeline and Expert LeadershipApril 9, 2024 | usnews.comLaunch of Russia's Angara Rocket Set for Wednesday, Roscosmos SaysApril 5, 2024 | msn.comRocket Mortgage responds to Suns owner Mat Ishbia's remarks about company, Dan GilbertApril 4, 2024 | msn.com2024 NCAA Women's Basketball Final Four: Schedule for games at Cleveland's Rocket Mortgage FieldHouseApril 2, 2024 | seekingalpha.comRocket Pharmaceuticals: Multiple Regulatory Submissions Make It A Must WatchApril 1, 2024 | msn.comGentle Mates take Major 1 title at Rocket League Championship SeriesMarch 31, 2024 | msn.comCoolest Feature Of The 2024 Triumph Rocket StormMarch 30, 2024 | msn.comFortnite & Rocket League: Mandalorian Crossover LeakedSee More Headlines Receive RCKTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:RCKTW CUSIPN/A CIK1281895 Webwww.rocketpharma.com Phone16464409100FaxN/AEmployees240Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Gaurav D. Shah M.D. (Age 48)CEO & Director Comp: $920.2kMs. Kinnari Patel M.B.A. (Age 44)MBA, Pharm.D., PharmD, Pres & COO Comp: $717.82kMr. Martin Louis Wilson J.D. (Age 47)Gen. Counsel, Chief Compliance Officer & Sr. VP Comp: $149.95kMr. Jonathan Schwartz (Age 59)Chief Medical Officer & Sr. VP of Clinical Devel. Comp: $557.79kMr. John C. Militello CPA (Age 50)CPA, Interim Principal Financial Officer, VP, Sr. Controller, Treasurer & Principal Accounting Officer Mr. Mayo PujolsChief Technical Officer, Exec. VP & DirectorMs. Jessie Yeung M.B.A.VP of Investor Relations & Corp. Fin.Kevin GiordanoDirector of Corp. CommunicationsMs. Isabel Carmona J.D.Sr. VP & Chief HR OfficerDr. Gayatri R. Rao J.D.M.D., Chief Devel. Officer of LVV & Sr. VPMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All Competitors RCKTW Stock Analysis - Frequently Asked Questions How have RCKTW shares performed in 2024? Rocket Pharmaceuticals' stock was trading at $0.49 at the beginning of the year. Since then, RCKTW stock has decreased by 75.5% and is now trading at $0.1199. View the best growth stocks for 2024 here. How do I buy shares of Rocket Pharmaceuticals? Shares of RCKTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RCKTW) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.